Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Viruses
Entry Details
ID
3024
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
Q7T6X2 (Created: 2006-10-17 Updated: 2009-01-20)
UniProtKB/Swiss-Prot Entry Name
YR826_MIMIV
Protein Name
Putative serine/threonine-protein kinase/receptor R826
Gene
MIMI_R826
Organism Scientific
Acanthamoeba polyphaga mimivirus
Organism Common
APMV
Lineage
Viruses
dsDNA viruses, no RNA stage
Mimiviridae
Mimivirus
Protein Length [aa]
1657
Protein Mass [Da]
186740
Features
Type
Description
Status
Start
End
signal peptide
potential
1
23
chain
Putative serine/threonine-protein kinase/receptor R826
24
1657
transmembrane region
potential
742
762
domain
Protein kinase 1
786
1049
domain
Guanylate cyclase
1134
1277
domain
Protein kinase 2
1399
1651
glycosylation site
N-linked (GlcNAc...)
potential
153
153
glycosylation site
N-linked (GlcNAc...)
potential
178
178
glycosylation site
N-linked (GlcNAc...)
potential
238
238
glycosylation site
N-linked (GlcNAc...)
potential
255
255
glycosylation site
N-linked (GlcNAc...)
potential
352
352
glycosylation site
N-linked (GlcNAc...)
potential
454
454
glycosylation site
N-linked (GlcNAc...)
potential
476
476
glycosylation site
N-linked (GlcNAc...)
potential
494
494
glycosylation site
N-linked (GlcNAc...)
potential
596
596
active site
Proton acceptor
by similarity
909
909
active site
Proton acceptor
by similarity
1522
1522
binding site
ATP
by similarity
813
813
binding site
ATP
by similarity
1426
1426
compositionally biased region
Poly-Ser
1058
1065
nucleotide phosphate-binding region
ATP
by similarity
792
800
nucleotide phosphate-binding region
ATP
by similarity
1405
1413
SP Length
23
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MRLNSQIVFCIVVVISCLSMIEC
Sequence
MRLNSQIVFCIVVVISCLSMIEC
KMGSRIYCSGSLSSVELFSQYISNYAL
RNDDVTIIYAGMSVDEINADVYIADCSAYDRAIPQIYMISYGLIQFPIVG
QAIVIIYNVPGLSSHNMIIDRETLGRIWTGNIRKWNDIQIQNLNPDIASQ
LP
N
ETITLGYNDAYYLSISEIMQLALR
N
FSEEFANAHTIAGGKFGNMIPA
KQGYAIDAGEASESRIDWVKNTPFSLSFADFATVYPR
N
VSYMHMYNKAGK
LVEP
N
ITTVQSAMADFKEIYTTNDFTIDIFDASGENSWPISWVNYISMTS
TFQQADCIRTKELLDFIAWFYMNNEIAEIIKEYQYYPLDNTIKKIAIDNM
Y
N
VTCNGKVSQEHQYLIAFGSPLSIMASWPNTWASSMTTVKYYASLSDQA
IELQKTFSGDFGITIKDFDKNKYLSSTMEDIGVSHLAAFNIVPAYNIPEF
IGL
N
ETLVLNYETIVDIYLGLVTNW
N
DSSIRNSNNPYINSLLP
N
KTITVV
VQKVESDVNELFTNFLSCKSDKFNNAIGPTNLPEFDFVSNNVVYTEDVYG
VGNTLVSTDYSFAFWPEPGIRLLSHMAIVQAASIQTSTGTIIKPT
N
ETLS
KAVDNKINSINRRDIEDGSWPFIAMMSLVYHQKTMQSFSKASALADFIYW
TQFDDTAASIADTQGYYVASIHPTILRENLELLQSFTFEDRTVSKVANCI
FEGTICYNKGTCNNNVCLCNIDREGQFCELEKTQSDTNIVT
IILAVVIPI
AFIIVCIICILV
VALIFSLRFRKGISDDWEIDFHE
LELGEQ
LGTGAFGEV
HKGTWRGTEVAV
K
MISPDKTITKDIERNFKDEVRVMTTLRHPNVVLFMAA
STKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAYQASKGMHFL
HSSGITHR
D
LKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQ
WTAPEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVI
RDNYRPVISDQLRSEVAPEYIELLTSCWHFDPTIRPTFLEIMTRLSNLM
G
DSGMTGM
SSSSSNSS
KFDYNSFGKVQQFAINRTDPDGIVQNSYNRTDSYD
LGSNNSHSSITSDTNKSNKYLRQTNIQHPTGEV
VVVFTDIISAAQLWEFD
ASEMKNATILYNKLVRSICNECGGYESLISKERNSGEGSFCLIFSDVQNA
ITFCEELQKQLVGVNWSPKLLEHPITAIEKDINGTIIYAGLRVRIGLHFG
STKINYDPISRKYEYIGPTVTTAAAVT
TITHGGQIIMTEDVANKLSTENS
NKPVCLGRVDIDGIPDSLVLYEYVISALIGRFFGGVTRKNASFVSNETST
DYDDMDTDNSTFSARVPHQAYQYHAAIENNERYLTSAGLCSWVINYDE
IK
MGEQ
IGLGSYGVV
YRGKWKNVDVAI
K
KFIKQKIDENHLLGIREEIAFLKK
LHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKI
LVNIAKGISYLHSFDPPIIHR
D
IKPSNILIDENWNVKIADFGFARIKEEN
AIMTRCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANF
MKITMDILEDVRPKIPQDCPEEFAKLMRKCWHAKSTKRPTMDDVIIVLAK
F
CPDISV
Original
MRLNSQIVFCIVVVISCLSMIECKMGSRIYCSGSLSSVELFSQYISNYAL
RNDDVTIIYAGMSVDEINADVYIADCSAYDRAIPQIYMISYGLIQFPIVG
QAIVIIYNVPGLSSHNMIIDRETLGRIWTGNIRKWNDIQIQNLNPDIASQ
LPNETITLGYNDAYYLSISEIMQLALRNFSEEFANAHTIAGGKFGNMIPA
KQGYAIDAGEASESRIDWVKNTPFSLSFADFATVYPRNVSYMHMYNKAGK
LVEPNITTVQSAMADFKEIYTTNDFTIDIFDASGENSWPISWVNYISMTS
TFQQADCIRTKELLDFIAWFYMNNEIAEIIKEYQYYPLDNTIKKIAIDNM
YNVTCNGKVSQEHQYLIAFGSPLSIMASWPNTWASSMTTVKYYASLSDQA
IELQKTFSGDFGITIKDFDKNKYLSSTMEDIGVSHLAAFNIVPAYNIPEF
IGLNETLVLNYETIVDIYLGLVTNWNDSSIRNSNNPYINSLLPNKTITVV
VQKVESDVNELFTNFLSCKSDKFNNAIGPTNLPEFDFVSNNVVYTEDVYG
VGNTLVSTDYSFAFWPEPGIRLLSHMAIVQAASIQTSTGTIIKPTNETLS
KAVDNKINSINRRDIEDGSWPFIAMMSLVYHQKTMQSFSKASALADFIYW
TQFDDTAASIADTQGYYVASIHPTILRENLELLQSFTFEDRTVSKVANCI
FEGTICYNKGTCNNNVCLCNIDREGQFCELEKTQSDTNIVTIILAVVIPI
AFIIVCIICILVVALIFSLRFRKGISDDWEIDFHELELGEQLGTGAFGEV
HKGTWRGTEVAVKMISPDKTITKDIERNFKDEVRVMTTLRHPNVVLFMAA
STKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAYQASKGMHFL
HSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQ
WTAPEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVI
RDNYRPVISDQLRSEVAPEYIELLTSCWHFDPTIRPTFLEIMTRLSNLMG
DSGMTGMSSSSSNSSKFDYNSFGKVQQFAINRTDPDGIVQNSYNRTDSYD
LGSNNSHSSITSDTNKSNKYLRQTNIQHPTGEVVVVFTDIISAAQLWEFD
ASEMKNATILYNKLVRSICNECGGYESLISKERNSGEGSFCLIFSDVQNA
ITFCEELQKQLVGVNWSPKLLEHPITAIEKDINGTIIYAGLRVRIGLHFG
STKINYDPISRKYEYIGPTVTTAAAVTTITHGGQIIMTEDVANKLSTENS
NKPVCLGRVDIDGIPDSLVLYEYVISALIGRFFGGVTRKNASFVSNETST
DYDDMDTDNSTFSARVPHQAYQYHAAIENNERYLTSAGLCSWVINYDEIK
MGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKK
LHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKI
LVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEEN
AIMTRCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANF
MKITMDILEDVRPKIPQDCPEEFAKLMRKCWHAKSTKRPTMDDVIIVLAK
FCPDISV
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11